Digital Accelerating digital healthcare, with VITA Last month, pharmaphorum travelled to Rome to cover the inaugural VITA Accelerator demo day.
News Grail plans FDA filing for cancer blood test after new trial Grail is eyeing FDA approval of its Galleri cancer screening blood test after a second positive phase 3 trial.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
